JOHN PAGE: Open Payments
NPI 1871679654 · GRAPEVINE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$448 in 23 payments from 10 companies in 2025. Trend: 2023 $372 · 2024 $471 · 2025 $448
Food & beverage: $448
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $81 |
| AstraZeneca Pharmaceuticals LP | 4 | $72 |
| ABBVIE INC. | 4 | $61 |
| Astellas Pharma US Inc | 3 | $53 |
| Novo Nordisk Inc | 2 | $47 |
| Abbott Laboratories | 2 | $36 |
| Amgen Inc. | 2 | $34 |
| Verity Pharmaceuticals Inc. | 1 | $25 |
| Exact Sciences Corporation | 1 | $22 |
| Dexcom, Inc. | 1 | $19 |
Products named: Auvelity, BREZTRI, Veozah, VRAYLAR, FREESTYLE LIBRE 3, OTEZLA, Tlando, Cologuard Collection Kit.
Industry payments across TX — which companies pay providers there.
